Details for Patent: 9,127,013
✉ Email this page to a colleague
Which drugs does patent 9,127,013 protect, and when does it expire?
Patent 9,127,013 protects VITRAKVI and is included in two NDAs.
This patent has one hundred and ten patent family members in thirty-eight countries.
Summary for Patent: 9,127,013
| Title: | Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
| Abstract: | Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal. |
| Inventor(s): | Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Boulder, CO) |
| Assignee: | Array BioPharma, Inc. (Boulder, CO) |
| Application Number: | 14/596,611 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,127,013
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-001 | Nov 26, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-002 | Nov 26, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Bayer Healthcare | VITRAKVI | larotrectinib sulfate | SOLUTION;ORAL | 211710-001 | Nov 26, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,127,013
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3106463 | ⤷ Sign Up | 301033 | Netherlands | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | PA2020504 | Lithuania | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | CA 2020 00013 | Denmark | ⤷ Sign Up |
| European Patent Office | 3106463 | ⤷ Sign Up | 122020000012 | Germany | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
